Clinical Trials

NCT03573700 | ACTIVE_NOT_RECRUITING | PHASE1/PHASE2

24 participants

Evaluation of CD19-Specific CAR Engineered Autologous T-Cells for Treatment of Relapsed/Refractory CD19+ Acute Lymphoblastic Leukemia

Study Type:

INTERVENTIONAL

Last Updated:

2026-08-11

Start Date:

2018-07-24

Completion:

2023-07-01

Conditions

• Acute Lymphoblastic Leukemia, in Relapse
• Acute Lymphoblastic Leukemia, Refractory

Interventions

• DRUG
• DEVICE
• BIOLOGICAL

Results Available

NCT03571373 | RECRUITING

1500 participants

PIBD-SETQuality: the Inception Cohort and Safety Registry

Study Type:

OBSERVATIONAL

Last Updated:

2026-08-11

Start Date:

2017-01-03

Completion:

2030-12-31

Conditions

• Inflammatory Bowel Diseases
• Crohn Disease
• Ulcerative Colitis

Interventions

• OTHER

No Results Yet

NCT03545607 | TERMINATED | PHASE3

206 participants

MultiStem® Administration for Stroke Treatment and Enhanced Recovery Study

Study Type:

INTERVENTIONAL

Last Updated:

2026-08-11

Start Date:

2018-07-28

Completion:

2024-10-01

Conditions

• Ischemic Stroke

Interventions

• BIOLOGICAL

No Results Yet

NCT03527992 | COMPLETED | NA

59 participants

Automated Oxygen Administration in Patients With Hypoxemic Pneumonia and Pleuropneumonia

Study Type:

INTERVENTIONAL

Last Updated:

2026-08-11

Start Date:

2018-03-09

Completion:

2024-10-03

Conditions

• Pneumonia
• Pneumonia, Ventilator-Associated
• Length of Stay

Interventions

• DEVICE

No Results Yet

NCT03506061 | COMPLETED | PHASE2

42 participants

Trikafta in Cystic Fibrosis Patients

Study Type:

INTERVENTIONAL

Last Updated:

2026-08-11

Start Date:

2019-09-04

Completion:

2024-02-13

Conditions

• Cystic Fibrosis

Interventions

• DRUG

Results Available

NCT03505762 | ACTIVE_NOT_RECRUITING | PHASE2

80 participants

Tailored Prednisone Reduction in Preventing Hyperglycemia in Participants With B-Cell Non-Hodgkin Lymphoma Receiving Combination Chemotherapy Treatment

Study Type:

INTERVENTIONAL

Last Updated:

2026-08-11

Start Date:

2018-07-19

Completion:

2024-03-28

Conditions

• B-Cell Non-Hodgkin Lymphoma

Interventions

• DRUG
• OTHER
• BIOLOGICAL

Results Available

NCT03495882 | COMPLETED | PHASE1/PHASE2

175 participants

A Study of Zalifrelimab and Balstilimab for Treatment of Participants With Metastatic or Locally Advanced Solid Tumors, and Expansion Into Select Solid Tumors (Cervical)

Study Type:

INTERVENTIONAL

Last Updated:

2026-08-11

Start Date:

2017-12-18

Completion:

2022-07-15

Conditions

• Cervical Cancer

Interventions

• DRUG

Results Available

NCT03448003 | ACTIVE_NOT_RECRUITING | NA

60 participants

Comprehensive Lifestyle Change To Prevent Breast Cancer

Study Type:

INTERVENTIONAL

Last Updated:

2026-08-11

Start Date:

2019-04-04

Completion:

2027-08-31

Conditions

• Premenopausal

Interventions

• OTHER

No Results Yet

NCT03424421 | ACTIVE_NOT_RECRUITING | NA

15 participants

Anterior Shoulder Instability Treated With a Semitendinosus Subscapular Sling Procedure

Study Type:

INTERVENTIONAL

Last Updated:

2026-08-11

Start Date:

2017-12-20

Completion:

2024-02-05

Conditions

• Anterior Shoulder Dislocation
• Joint Instability

Interventions

• PROCEDURE

No Results Yet

NCT03422302 | RECRUITING | NA

30 participants

Continuous Positive Airway Pressure Device or Deep Inspiration Breath Hold in Reducing Tumor Motion in Patients Undergoing Stereotactic Body Radiation Therapy for Lung Cancer

Study Type:

INTERVENTIONAL

Last Updated:

2026-08-11

Start Date:

2018-03-16

Completion:

2028-05-31

Conditions

• Lung Carcinoma
• Malignant Respiratory Tract Neoplasm
• Metastatic Malignant Neoplasm in the Lung

Interventions

• DEVICE
• PROCEDURE
• RADIATION

No Results Yet

NCT03408353 | RECRUITING

10000 participants

Mammography, Early Detection Biomarkers, Risk Assessment, and Imaging Technologies, MERIT Study

Study Type:

OBSERVATIONAL

Last Updated:

2026-08-11

Start Date:

2017-09-15

Completion:

2027-04-30

Conditions

• Breast Carcinoma

Interventions

• OTHER
• PROCEDURE

No Results Yet

NCT03392246 | ACTIVE_NOT_RECRUITING | PHASE2

25 participants

A Phase 2 Study of Osimertinib in Combination With Selumetinib in EGFR Inhibitor naïve Advanced EGFR Mutant Lung Cancer

Study Type:

INTERVENTIONAL

Last Updated:

2026-08-11

Start Date:

2018-01-31

Completion:

2027-06-30

Conditions

• Non-small Cell Lung Cancer

Interventions

• DRUG

No Results Yet

NCT03391778 | ENROLLING_BY_INVITATION | PHASE1

250 participants

Adoptive Cell Therapy Long-term Follow-up (LTFU) Study

Study Type:

INTERVENTIONAL

Last Updated:

2026-08-11

Start Date:

2018-04-09

Completion:

2032-04-01

Conditions

• Neoplasms

Interventions

• BIOLOGICAL

No Results Yet

NCT03385499 | COMPLETED | NA

70 participants

New Diagnostic Approach for Congenital Toxoplasmosis

Study Type:

INTERVENTIONAL

Last Updated:

2026-08-11

Start Date:

2018-06-20

Completion:

2023-12-25

Conditions

• Congenital Toxoplasmosis

Interventions

• BIOLOGICAL

No Results Yet

NCT03381287 | COMPLETED | PHASE1/PHASE2

50 participants

A Multiple Ascending Dose Study of HTD1801 in Adults With Hypercholesterolemia

Study Type:

INTERVENTIONAL

Last Updated:

2026-08-11

Start Date:

2018-04-13

Completion:

2018-12-31

Conditions

• Hypercholesterolemia

Interventions

• DRUG

Results Available

NCT03307980 | COMPLETED | PHASE2

21 participants

Long-term Safety and Efficacy Study and Dose-Escalation Substudy of PF 06838435 in Individuals With Hemophilia B

Study Type:

INTERVENTIONAL

Last Updated:

2026-08-11

Start Date:

2017-06-22

Completion:

2026-07-23

Conditions

• Hemophilia B

Interventions

• BIOLOGICAL

No Results Yet

NCT03220022 | ACTIVE_NOT_RECRUITING | PHASE1

46 participants

Ibrutinib, Rituximab, Etoposide, Prednisone, Vincristine Sulfate, Cyclophosphamide, and Doxorubicin Hydrochloride in Treating Patients With HIV-Positive Stage II-IV Diffuse Large B-Cell Lymphomas

Study Type:

INTERVENTIONAL

Last Updated:

2026-08-11

Start Date:

2018-03-16

Completion:

2024-10-10

Conditions

• AIDS-Related Lymphoma
• Ann Arbor Stage II Diffuse Large B-Cell Lymphoma
• Ann Arbor Stage III Diffuse Large B-Cell Lymphoma
• Ann Arbor Stage IV Diffuse Large B-Cell Lymphoma

Interventions

• DRUG
• BIOLOGICAL
• OTHER

Results Available

NCT03215095 | ACTIVE_NOT_RECRUITING | EARLY_PHASE1

11 participants

RAI Plus Immunotherapy for Recurrent/Metastatic Thyroid Cancers

Study Type:

INTERVENTIONAL

Last Updated:

2026-08-11

Start Date:

2017-07-10

Completion:

2023-02-06

Conditions

• Thyroid Cancer

Interventions

• DRUG
• RADIATION

Results Available

NCT03199209 | ACTIVE_NOT_RECRUITING | NA

600 participants

Your Health Matters! (Tu Salud ¡Si Cuenta!): Promoting Healthy Lifestyles in Latino Families

Study Type:

INTERVENTIONAL

Last Updated:

2026-08-11

Start Date:

2016-06-06

Completion:

2028-12-31

Conditions

• Family Member
• Health Status Unknown

Interventions

• OTHER
• BEHAVIORAL

No Results Yet

NCT03099603 | COMPLETED | PHASE1

32 participants

A Study of HTD1801 in Healthy Subjects

Study Type:

INTERVENTIONAL

Last Updated:

2026-08-11

Start Date:

2017-03-24

Completion:

2017-07-11

Conditions

• Primary Sclerosing Cholangitis

Interventions

• DRUG

No Results Yet

NCT03081910 | RECRUITING | PHASE1

54 participants

Autologous T-Cells Expressing a Second Generation CAR for Treatment of T-Cell Malignancies Expressing CD5 Antigen

Study Type:

INTERVENTIONAL

Last Updated:

2026-08-11

Start Date:

2017-11-01

Completion:

2028-06-01

Conditions

• T-cell Acute Lymphoblastic Lymphoma
• T-non-Hodgkin Lymphoma
• T-cell Acute Lymphoblastic Leukemia

Interventions

• GENETIC

No Results Yet

NCT03034356 | COMPLETED | PHASE1/PHASE2

67 participants

Reducing Hippocampal Hyperactivity and Improving Cognition in Schizophrenia

Study Type:

INTERVENTIONAL

Last Updated:

2026-08-11

Start Date:

2018-08-15

Completion:

2024-06-30

Conditions

• Schizophrenia

Interventions

• DRUG

Results Available

NCT02889523 | ACTIVE_NOT_RECRUITING | PHASE1/PHASE2

214 participants

Study of Tazemetostat in Newly Diagnosed Diffuse Large B Cell and Follicular Lymphoma Patients Treated by Chemiotherapy

Study Type:

INTERVENTIONAL

Last Updated:

2026-08-11

Start Date:

2016-10-31

Completion:

2023-01-31

Conditions

• Lymphoma
• DLBCL
• Follicular Lymphoma

Interventions

• DRUG

No Results Yet

NCT02884648 | ACTIVE_NOT_RECRUITING | PHASE2

35 participants

Bevacizumab in Ovarian Cancer Patients With Disease at Second-Look Surgery

Study Type:

INTERVENTIONAL

Last Updated:

2026-08-11

Start Date:

2016-11-15

Completion:

2027-02-02

Conditions

• Malignant Neoplasms of Female Genital Organs
• Ovarian Cancer
• Fallopian Tube Cancer
• Primary Peritoneal Cancer

Interventions

• DRUG

No Results Yet

NCT02776254 | COMPLETED | NA

3100 participants

Differentiated Care for Improved Health Systems Efficiency and Health Outcomes in Zambia

Study Type:

INTERVENTIONAL

Last Updated:

2026-08-11

Start Date:

2016-03-31

Completion:

2017-07-31

Conditions

• HIV

Interventions

• OTHER

No Results Yet

NCT02756897 | ACTIVE_NOT_RECRUITING | PHASE2

234 participants

Venetoclax and Ibrutinib in Treating Patients With Chronic or Small Lymphocytic Leukemia

Study Type:

INTERVENTIONAL

Last Updated:

2026-08-11

Start Date:

2016-07-07

Completion:

2027-07-01

Conditions

• Chronic Lymphocytic Leukemia
• Recurrent Chronic Lymphocytic Leukemia
• Recurrent Small Lymphocytic Lymphoma
• Refractory Chronic Lymphocytic Leukemia
• Refractory Small Lymphocytic Lymphoma
• Small Lymphocytic Lymphoma

Interventions

• DRUG
• OTHER

No Results Yet

NCT02581930 | COMPLETED | PHASE2

18 participants

Ibrutinib in Treating Patients With Refractory Metastatic Cutaneous Melanoma

Study Type:

INTERVENTIONAL

Last Updated:

2026-08-11

Start Date:

2016-12-16

Completion:

2021-09-09

Conditions

• Metastatic Melanoma
• Recurrent Cutaneous Melanoma
• Stage IV Cutaneous Melanoma AJCC v6 and v7

Interventions

• DRUG
• OTHER

Results Available

NCT02541955 | COMPLETED | PHASE4

40 participants

Use of Acthar in Rheumatoid Arthritis (RA) Related Flares

Study Type:

INTERVENTIONAL

Last Updated:

2026-08-11

Start Date:

2017-07-20

Completion:

2025-05-06

Conditions

• Rheumatoid Arthritis (RA)

Interventions

• DRUG

Results Available

NCT02538848 | COMPLETED | PHASE1

32 participants

Study of HTD4010 in Healthy Volunteers

Study Type:

INTERVENTIONAL

Last Updated:

2026-08-11

Start Date:

2015-10-31

Completion:

2016-03-31

Conditions

• Type 2 Diabetes Mellitus

Interventions

• DRUG

No Results Yet

NCT02438189 | COMPLETED | NA

33 participants

Reduction of Nocturnal Hypoglycemia and Hyperglycemia in the Home Using Predictive Algorithms

Study Type:

INTERVENTIONAL

Last Updated:

2026-08-11

Start Date:

2015-06-30

Completion:

2016-03-31

Conditions

• Type 1 Diabetes

Interventions

• DEVICE

Results Available

NCT02436707 | ACTIVE_NOT_RECRUITING | PHASE2

129 participants

Novel Combination Therapy in the Treatment of Relapsed and Refractory Aggressive B-Cell Lymphoma

Study Type:

INTERVENTIONAL

Last Updated:

2026-08-11

Start Date:

2015-10-27

Completion:

2026-12-31

Conditions

• Lymphoma

Interventions

• DRUG

No Results Yet

NCT02422550 | RECRUITING

937 participants

Imaging Acquisition and Analysis Methods for Optimization of MRI Radiation Oncology Simulation and Response Assessment

Study Type:

OBSERVATIONAL

Last Updated:

2026-08-11

Start Date:

2015-04-09

Completion:

2027-04-30

Conditions

• Radiation Therapy

Interventions

• DEVICE

No Results Yet

NCT02320435 | ACTIVE_NOT_RECRUITING | PHASE3

154 participants

A Safety and Efficacy Extension Study of Pertuzumab in Patients With Solid Tumors Previously Enrolled in a Hoffmann-La Roche-Sponsored Pertuzumab Clinical Trial

Study Type:

INTERVENTIONAL

Last Updated:

2026-08-11

Start Date:

2015-02-02

Completion:

2026-12-31

Conditions

• Solid Tumors

Interventions

• DRUG

No Results Yet

NCT02071134 | RECRUITING

1500 participants

Registry of Deep Brain Stimulation With the VERCISE™ System: Vercise DBS Registry

Study Type:

OBSERVATIONAL

Last Updated:

2026-08-11

Start Date:

2014-03-04

Completion:

2038-12-31

Conditions

• Parkinson's Disease

Interventions

• DEVICE

No Results Yet

NCT01989585 | ACTIVE_NOT_RECRUITING | PHASE1/PHASE2

75 participants

Testing the Addition of Navitoclax to the Combination of Dabrafenib and Trametinib in People Who Have BRAF Mutant Melanoma

Study Type:

INTERVENTIONAL

Last Updated:

2026-08-11

Start Date:

2014-03-24

Completion:

2027-12-31

Conditions

• Clinical Stage III Cutaneous Melanoma AJCC v8
• Clinical Stage IV Cutaneous Melanoma AJCC v8
• Malignant Solid Neoplasm
• Metastatic Melanoma
• Unresectable Melanoma

Interventions

• PROCEDURE
• DRUG
• OTHER
• BIOLOGICAL

No Results Yet

NCT01856296 | COMPLETED | NA

303 participants

A Study to Select Rational Therapeutics Based on the Analysis of Matched Tumor and Normal Biopsies in Subjects With Advanced Malignancies

Study Type:

INTERVENTIONAL

Last Updated:

2026-08-11

Start Date:

2013-04-23

Completion:

2015-12-07

Conditions

• Metastatic Cancer

Interventions

• PROCEDURE

No Results Yet

NCT01786265 | ACTIVE_NOT_RECRUITING | PHASE2

310 participants

Finite Androgen Ablation With or Without Abiraterone Acetate and Prednisone in Treating Patients With Recurrent Prostate Cancer

Study Type:

INTERVENTIONAL

Last Updated:

2026-08-11

Start Date:

2013-02-05

Completion:

2027-02-01

Conditions

• Prostate Adenocarcinoma
• Recurrent Prostate Carcinoma

Interventions

• DRUG

No Results Yet

NCT01719055 | RECRUITING

4800 participants

RELIEF - A Global Prospective Observational Post-Market Study to Evaluate Long-Term Effectiveness of Neurostimulation Therapy for Pain

Study Type:

OBSERVATIONAL

Last Updated:

2026-08-11

Start Date:

2012-11-19

Completion:

2035-05-31

Conditions

• Pain

Interventions

• DEVICE

No Results Yet

NCT01437787 | TERMINATED | PHASE3

289 participants

Phase III Study of SAR302503 in Intermediate-2 and High Risk Patients With Myelofibrosis

Study Type:

INTERVENTIONAL

Last Updated:

2026-08-11

Start Date:

2011-12-31

Completion:

2014-06-30

Conditions

• Hematopoietic Neoplasm

Interventions

• DRUG

Results Available

NCT01434368 | RECRUITING

480 participants

A Longitudinal Investigation of the Endocrine and Neurobiologic Events Accompanying Puberty

Study Type:

OBSERVATIONAL

Last Updated:

2026-08-11

Start Date:

2011-11-23

Conditions

• fMRI

No Results Yet